Product Details

Octreotide for Injectable Suspension

Octreotide
30 mg
Powder for Injectable Suspension
Vial + Diluent in Prefilled Syringe Kit

DIN/PIN/NPN

02503786

Manufacturer

Teva Canada Limited

Formulary Listing Date

2021-11-30  

Unit Price

1094.7600

Amount MOH Pays

1094.7600

Coverage Status

General Benefit

ODB Formulary Therapeutic Classification

Therapeutic Note

NO

ATC Code

H01CB02

Interchangeable Products

DIN/ PIN/ NPN Brand name Unit Price Amount MOH pays
02503786 Octreotide for Injectable Suspension 1094.7600 1094.7600
 

LU Clinical Criteria

NO  

Requirements


EAP Criteria

  NO

Product Monograph

View Monograph